Etanercept use associated with significant increases in height, weight, BMI in children with arthritis
Posted on Thu, Jan 27, 2011
Formulary , 01/27/2011 Free full text Clinical Article
Researchers from the Cincinnati Children's Hospital Medical Center have demonstrated that the tumor necrosis factor (TNF)–alpha inhibitor etanercept is associated with significant increases in height, weight, and body mass index (BMI) in children with juvenile idiopathic arthritis (JIA), according to a study recently...read more
Read all Pediatrics articles at MDLinx.com